TMO
April 23, 2025 - AI Summary
Undervalued by 69.5% based on the discounted cash flow analysis.
Market cap | $162.07 Billion |
---|---|
Enterprise Value | $192.12 Billion |
Dividend Yield | $1.64 (0.38199054340484%) |
Earnings per Share | $16.58 |
Beta | 0.78 |
Outstanding Shares | 378,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 24.91 |
---|---|
PEG | 184.8 |
Price to Sales | 3.8 |
Price to Book Ratio | 3.3 |
Enterprise Value to Revenue | 4.48 |
Enterprise Value to EBIT | 30.37 |
Enterprise Value to Net Income | 29 |
Total Debt to Enterprise | 0.18 |
Debt to Equity | 0.69 |
No data
No data
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...